The differences between the left-side and the right-sided colon cancer

doi:10.3877/cma.j.issn.2095-3224.2018.06.003

Abstract

Abstract:

Recent researches discovered that the left and right colon cancer are two different diseases, which differ significantly in clinical features, epidemiology, histology, molecular biology, targeted drug treatment and prognosis. So the treatments for the left and right colon cancer are different. Further understanding of the differences between the left and right colon cancers can guide clinicians to make accurate individual evaluations and precise treatments for patients in the era of accurate medical treatment.

Key words: Colon neoplasms, Left-sided colonic neoplasms, Right-sided colonic neoplasms, Molecular biology, Prognosis

Jilin Hu, Yun Lu. The differences between the left-side and the right-sided colon cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2018, 07(06): 514-517.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjzcjbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3224.2018.06.003

https://zhjzcjbdzzz.cma-cmc.com.cn/EN/Y2018/V07/I06/514

References 26

[1]	Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014 [J]. CA Cancer J Clin, 2014, 64(1): 9-29.
[2]	Chen WQ, Zhang SR, Zhang SW, et al. Report of cancer incidence and mortality in China, 2012 [J]. China Cancer, 2016, 25(1): 1-8.
[3]	Benedix F, Kube R, Meyer F, et al. Comparison of 17, 641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival [J]. Dis Colon Rectum, 2010, 53(1): 57-64.
[4]	Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location [J]. Ann Intern Med, 1990, 113(10): 779-788.
[5]	Cheng L, Eng C, Nieman LZ, et al. Trends in colo-rectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005 [J]. Am J Clin Oncol, 2011, 34(6): 573-580.
[6]	Boise MK, Johansen JS, Dehlendorff C, et al. Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer [J]. Annals of Oncology, 2013, 24(10): 2554-2559.
[7]	Carethers JM. One colon lumen but two organs [J]. Gastroenterology, 2011, 141(2): 411-442.
[8]	Wu X, Chen VW, Martin J, et al. Sub-site-specific colorectal cancer incidence rates and stage distributions among Asians an d Pacific Islanders in the United States, 1995 to 1999 [J]. Cancer Epidemioly Biomarkers Prev, 2004, 13(7): 1215-1222.
[9]	Chin CC, Wang JY, Yeh CY, et al. Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases Ⅲ colon cancer [J]. Int J Colorectal Dis, 2009, 24(11): 1297-1302.
[10]	Albuquerque C, Bakker ER, van Veelen W, et al. Colorectal cancers choosing sides [J]. Biochim Biophys Acta, 2011, 1816(2): 219-231.
[11]	Rebecca LS, Elizabeth MW, Ahmedin J. Trends in Colorectal Cancer Incidence Rates in the United States by Tumor Location and Stage, 1992–2008 [J]. American Association for Cancer Research, 2012, 21(3): 411-416.
[12]	Price TJ, Beeke C, Ullah S, et al. Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease [J]. Cancer, 2015, 121(6): 830-835.
[13]	Weiss JM, Pfau PR, OʹConnor ES, et al. Mortality by stage for right-versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results-Medicare data [J]. J Clin Oncol: official journal of the American Society of Clinical Oncology, 2011, 29(33): 4401-4409.
[14]	Meguid RA, Slidell MB, Wolfgang CL, et al. Is there a difference in survival between right-versus left-sided colon cancers? [J]. Ann Surg Oncol, 2008, 15(9): 2388-2394.
[15]	Snaebjornsson P, Coupe VM, Jonasson L, et al. Colon cancer in Iceland--a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients age [J]. Int J Cancer, 2010, 127(11): 2645-2653.
[16]	Worthley DL, Leggett BA. Colorectal cancer: molecular features and clinical opportunities [J]. Clin Biochem Rev, 2010, 31(2): 31-38.
[17]	Nosho K, Irahara N, Shima K, et al. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample [J]. PloS One, 2008, 3(11): e3698.
[18]	Roth AD, Delorenzi M, Tejpar S, et al. Integrated analysis of molecular and clinical prognostic factors in stageⅡ/Ⅲ colon cancer [J]. J Natl Cancer Inst, 2012, 104(21): 1635-1646.
[19]	Bae JM, Kim JH, Cho NY, et al. Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumor location [J]. Br J Cancer, 2013, 109(4): 1004-1012.
[20]	Barault L, Charon-Barra C, Jooste V, et al. Hypermethylatorpheno type in sporadic colon cancer: study on a population-based series of 582 cases [J]. Cancer Res, 2008, 68(20): 8541-8546.
[21]	Weisenberger DJ, Siegmund KD, Campan M, et al. CpG islandmethylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer [J]. Nat Genet, 2006, 38(7): 787-793.
[22]	Russo A, Bazan V, Iacopetta B, et al. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment [J]. J Clin Oncol, 2005, 23(30): 7518-7528.
[23]	Brule SY, Jonker DJ, Karapetis CS, et al. Location of colon cancer (right-sided versus left-sided) as a pregnostic factor and a predictor of benefit from cetuximab in NCIC CO.17 [J]. Eur J Cancer, 2015, 51(11): 1405-1414.
[24]	von Einem JC, Heinemann V, von Weikersthal LF, et al. Left-sided primary tumors are associated with favorable prognosis in patients with KRAS cod on 1213 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial [J]. J Cancer Res Clin Oncol, 2014, 140(9): 1607-1614.
[25]	Moritani K, Hasegawa H, Okabayashi K, et al. Difference in the recurrence rate between right- and left-sided colon cancer: a 17-year experience at a single institution [J]. Surg Today, 2014, 44(9): 1685-1691.
[26]	Gao P, Song YX, Xu YY, et al. Does the prognosis of colorectal mucinous carcinoma depend upon the primary tumor site? Results from two independent databases [J]. Histopathology, 2013, 63(5): 603-615.

Please choose a citation manager

Content to export